1. Field postmortem rabies rapid immunochromatographic diagnostic test for resource-limited settings with further molecular applications
- Author
-
Laurent Dacheux, Jakob Zinsstag, Hervé Bourhy, Paola De Benedictis, Pascal Cozette, Ibrahima Dicko, Enos Madaye, Pati Patient Pyana, Céline Mbilo, Morgane Gourlaouen, Emmanuel Couacy-Hymann, Casimir Kouakou, Vessaly Kallo, Abdallah Traoré, Service Naïssengar, Monique Léchenne, Stephanie Mauti, Lyssavirus, épidémiologie et neuropathologie - Lyssavirus Epidemiology and Neuropathology, Institut Pasteur [Paris] (IP), Environment and Sustainability Institute [Penryn, UK], University of Exeter, Institut de Recherche en Elevage pour le Developpement [N'Djamena, Tchad] (IRED), Laboratoire Central Vétérinaire [Bamako, Mali], Ecole Inter-États des Sciences et Médecine Vétérinaires de Dakar (EISMV), Direction des Services Vétérinaires, Laboratoire National d'Appui au Développement Agricole (LANADA), Laboratoire Central Vétérinaire de Bingerville, FAO Reference Centre for Rabies, Istituto Zooprofilattico Sperimentale delle Venezie (IZSVe), Swiss Tropical and Public Health Institute [Basel], University of Basel (Unibas), Institut National de Recherche Biomédicale [Kinshasa] (INRB), This work was supported through the Global Alliance for Vaccines and Immunisation (GAVI), the Wolfermann Nägeli Foundation, the Swiss African Research Cooperation (SARECO), the SWF Stiftung für wissenschaftliche Forschung, the Freiwillige Akademische Gesellschaft (FAG) Basel, the Bilateral Science and Technology Cooperation Programme of Switzerland with Asia and the Novartis Foundation for biomedical research., and Institut Pasteur [Paris]
- Subjects
0301 basic medicine ,Rabies ,MESH: Diagnosis ,General Chemical Engineering ,030231 tropical medicine ,medicine.disease_cause ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,0302 clinical medicine ,MESH: Rabies ,Diagnosis ,medicine ,Animals ,Sampling (medicine) ,MESH: Animals ,Direct fluorescent antibody ,MESH: Diagnostic Tests, Routine ,Protocol (science) ,Postmortem Diagnosis ,Immunoassay ,medicine.diagnostic_test ,General Immunology and Microbiology ,business.industry ,Diagnostic Tests, Routine ,Brain biopsy ,General Neuroscience ,Rabies virus ,Gold standard (test) ,medicine.disease ,Virology ,3. Good health ,MESH: Rabies virus ,030104 developmental biology ,[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology ,business ,MESH: Immunoassay - Abstract
International audience; Functional rabies surveillance systems are crucial to provide reliable data and increase the political commitment necessary for disease control. To date, animals suspected as rabies-positive must be submitted to a postmortem confirmation using classical or molecular laboratory methods. However, most endemic areas are in low-and middle-income countries where animal rabies diagnosis is restricted to central veterinary laboratories. Poor availability of surveillance infrastructure leads to serious disease underreporting from remote areas. Several diagnostic protocols requiring low technical expertise have been recently developed, providing opportunity to establish rabies diagnosis in decentralized laboratories. We present here a complete protocol for field postmortem diagnosis of animal rabies using a rapid immunochromatographic diagnostic test (RIDT), from brain biopsy sampling to the final interpretation. We complete the protocol by describing a further use of the device for molecular analysis and viral genotyping. RIDT easily detects rabies virus and other lyssaviruses in brain samples. The principle of such tests is simple: brain material is applied on a test strip where gold conjugated antibodies bind specifically to rabies antigens. The antigen-antibody complexes bind further to fixed antibodies on the test line, resulting in a clearly visible purple line. The virus is inactivated in the test strip, but viral RNA can be subsequently extracted. This allows the test strip, rather than the infectious brain sample, to be safely and easily sent to an equipped laboratory for confirmation and molecular typing. Based on a modification of the manufacturer's protocol, we found increased test sensitivity, reaching 98% compared to the gold standard June 2020 • 160 • e60008 • Page 2 of 29 reference method, the direct immunofluorescence antibody test. The advantages of the test are numerous: rapid, easy-to-use, low cost and no requirement for laboratory infrastructure, such as microscopy or cold-chain compliance. RIDTs represent a useful alternative for areas where reference diagnostic methods are not available.
- Published
- 2020
- Full Text
- View/download PDF